Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who ...

Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...

The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

The price of the deal was disclosed for the first time in bond filings, showing how it helped flip a net operating loss last ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Readers hoping to buy Quest Diagnostics Incorporated (NYSE:DGX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business ...

1 The provider will send the specimen to a nearby Quest Diagnostics testing laboratory. After testing, results will be provided to the physician and patient electronically. The physician may ...

SECAUCUS, N.J. - Quest Diagnostics (NYSE: DGX), a prominent player in the Healthcare Providers & Services industry with a market capitalization of $18.79 billion, has introduced a new FDA-cleared ...